BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27507786)

  • 1. Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome.
    Nilsson SR; Fejgin K; Gastambide F; Vogt MA; Kent BA; Nielsen V; Nielsen J; Gass P; Robbins TW; Saksida LM; Stensbøl TB; Tricklebank MD; Didriksen M; Bussey TJ
    Cereb Cortex; 2016 Oct; 26(10):3991-4003. PubMed ID: 27507786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine.
    Nilsson SRO; Heath CJ; Takillah S; Didienne S; Fejgin K; Nielsen V; Nielsen J; Saksida LM; Mariani J; Faure P; Didriksen M; Robbins TW; Bussey TJ; Mar AC
    Transl Psychiatry; 2018 Nov; 8(1):247. PubMed ID: 30429456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.
    Didriksen M; Fejgin K; Nilsson SR; Birknow MR; Grayton HM; Larsen PH; Lauridsen JB; Nielsen V; Celada P; Santana N; Kallunki P; Christensen KV; Werge TM; Stensbøl TB; Egebjerg J; Gastambide F; Artigas F; Bastlund JF; Nielsen J
    J Psychiatry Neurosci; 2017 Jan; 42(1):48-58. PubMed ID: 27391101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.
    Zarchi O; Diamond A; Weinberger R; Abbott D; Carmel M; Frisch A; Michaelovsky E; Gruber R; Green T; Weizman A; Gothelf D
    Eur Psychiatry; 2014 May; 29(4):203-10. PubMed ID: 24054518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependency of prepulse inhibition deficits on baseline startle reactivity in a mouse model of the human 22q11.2 microdeletion syndrome.
    Scarborough J; Mueller F; Weber-Stadlbauer U; Richetto J; Meyer U
    Genes Brain Behav; 2019 Apr; 18(4):e12523. PubMed ID: 30267483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of a novel mouse model of the 22q11.2 deletion syndrome: a model with the most common 3.0-Mb deletion at the human 22q11.2 locus.
    Saito R; Koebis M; Nagai T; Shimizu K; Liao J; Wulaer B; Sugaya Y; Nagahama K; Uesaka N; Kushima I; Mori D; Maruyama K; Nakao K; Kurihara H; Yamada K; Kano M; Fukada Y; Ozaki N; Aiba A
    Transl Psychiatry; 2020 Feb; 10(1):35. PubMed ID: 32066675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multitasking Abilities in Adolescents With 22q11.2 Deletion Syndrome: Results From an Experimental Ecological Paradigm.
    Schneider M; Eliez S; Birr J; Menghetti S; Debbané M; Van der Linden M
    Am J Intellect Dev Disabil; 2016 Mar; 121(2):151-64. PubMed ID: 26914469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stress.
    Tripathi A; Spedding M; Schenker E; Didriksen M; Cressant A; Jay TM
    Transl Psychiatry; 2020 Jan; 10(1):41. PubMed ID: 32066701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
    Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
    Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Functioning in Patients with 22q11.2 Deletion Syndrome: A Meta-Analytic Review.
    Moberg PJ; Richman MJ; Roalf DR; Morse CL; Graefe AC; Brennan L; Vickers K; Tsering W; Kamath V; Turetsky BI; Gur RC; Gur RE
    Behav Genet; 2018 Jul; 48(4):259-270. PubMed ID: 29922984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood cognitive development in 22q11.2 deletion syndrome: case-control study.
    Chawner SJRA; Doherty JL; Moss H; Niarchou M; Walters JTR; Owen MJ; van den Bree MBM
    Br J Psychiatry; 2017 Oct; 211(4):223-230. PubMed ID: 28882829
    [No Abstract]   [Full Text] [Related]  

  • 13. [22q11.2DS Syndrome as a Genetic Subtype of Schizophrenia].
    Huertas-Rodríguez CK; Payán-Gómez C; Forero-Castro RM
    Rev Colomb Psiquiatr; 2015; 44(1):50-60. PubMed ID: 26578219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
    Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
    Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-based prospective memory in children and adolescents with 22q11.2 deletion syndrome.
    Souchay C; Dubourg L; Ballhausen N; Schneider M; Cerf C; Schnitzspahn K; Faivre L; Kliegel M; Eliez S
    Clin Neuropsychol; 2018 Jul; 32(5):981-992. PubMed ID: 29132265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?
    Demily C; Franck N
    Eur J Med Genet; 2016 Nov; 59(11):596-603. PubMed ID: 27639442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome.
    Smerconish S; Schmitt JE
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationship Between Cognitive Control, Anxiety, and Restricted and Repetitive Behaviors in Children with 22q11.2 Deletion Syndrome.
    Uljarević M; McCabe KL; Angkustsiri K; Simon TJ; Hardan AY
    Autism Res; 2019 Dec; 12(12):1737-1744. PubMed ID: 31433576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.